Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 56480488000

Activities

Collapse all

Employment (4)

Silesian University of Technology: Gliwice, PL

2023-10-01 to present | Assistant Professor (Department of Systems Biology and Engineering)
Employment
Source: Self-asserted source
Katarzyna Malarz

University of Silesia: Katowice, PL

2022-12-01 to present | Associate Professor (Institute of Physics)
Employment
Source: Self-asserted source
Katarzyna Malarz

University of Silesia: Katowice, PL

2021-02-01 to 2022-11-30 | Assistant Professor (Institute of Physics)
Employment
Source: Self-asserted source
Katarzyna Malarz

University of Silesia: Katowice, PL

2018-03-01 to 2021-01-31 | PhD (Institute of Physics)
Employment
Source: Self-asserted source
Katarzyna Malarz

Professional activities (1)

Ministry of Science and Higher Education: Warsaw, PL

2020-08-10 | Scholarship of the Minister of Education and Science for outstanding young scientists
Distinction
Source: Self-asserted source
Katarzyna Malarz

Funding (2)

Nowe spojrzenie na wieloaspektową terapię celowaną w leczeniu glejaka wielopostaciowego.

2020-07-20 to 2024-07-20 | Grant
National Science Center (Krakow, PL)
URL: https://app.dimensions.ai/details/grant/grant.9333684
GRANT_NUMBER: 2019/35/B/NZ5/04208
Source: Self-asserted source
Katarzyna Malarz via DimensionsWizard

Spojrzenie na aktywność biologiczną i mechanizm działania nowych pochodnych styrylochinazoliny, jako inhibitorów kinaz tyrozynowych.

2017-09-29 to 2019-09-28 | Grant
National Science Center (Krakow, PL)
URL: https://app.dimensions.ai/details/grant/grant.7920611
GRANT_NUMBER:

2016/23/N/NZ7/00351
Source: Self-asserted source
Katarzyna Malarz via DimensionsWizard

Peer review (28 reviews for 8 publications/grants)

Review activity for Biomolecules. (2)
Review activity for Bioorganic chemistry. (3)
Review activity for Cancer chemotherapy and pharmacology. (1)
Review activity for Cancers. (5)
Review activity for European journal of medicinal chemistry. (6)
Review activity for Free radical biology & medicine. (1)
Review activity for International journal of molecular sciences. (8)
Review activity for Pharmaceutics. (2)
How many people are using ORCID?